CNIO - Spanish National Cancer Research Centre
Bruna Calsina Pla-Giribert serves as an Adjunct Professor in the Department of Biochemistry and Molecular Biology at the Universitat Autònoma de Barcelona since September 2022. Bruna has extensive research experience at the CNIO - Spanish National Cancer Research Centre, where roles include Postdoctoral and Predoctoral Researcher in the Hereditary Endocrine Cancer Group, focusing on the genomic and molecular characterization of metastatic paragangliomas and pheochromocytomas. Additional experience includes work as a Jr. Research Associate at Eli Lilly and Company in oncology, and an MSc researcher at University College London, studying drug delivery mechanisms. Bruna holds a Bachelor of Science in Biology from Universitat Autònoma de Barcelona, a Master of Science from UCL, and a PhD in Molecular Biology from Universidad Autónoma de Madrid. Currently enrolled in an executive education program at IE Business School, Bruna is enhancing business acumen in science and technology.
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.